CLINICAL_TRIALS
trial_result
· 2026-02-10
Clinical Trial Update: Study of Tecovirimat for Human Mpox Virus [Phase 3]
Summary
Phase 3 study of tecovirimat for mpox has been terminated; results have been posted (2026-02-10).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: MPOX | Phase 3 | Status: TERMINATED | Results posted: 2026-02-10